Published in Gastroenterology Week, September 18th, 2006
"The purpose of this study was to evaluate the effect of preoperative immunonutrition pharmaceutics (IMPACT) diet versus standard enteral nutrition (EN) on the nutritional status and immunity of patients with colorectal or GI cancer and to evaluate whether it influences the incidence of postoperative complication. Sixty patients with GI cancer were randomly divided into 2 groups, IM and control diet (CT), each of which was fed with IMPACT and conventional diet,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.